Homegrown flu vaccine gets green light

Published: 2009-07-24 07:00:00

Updated: 2009-07-24 07:00:00

Green Cross Corp. said on July 22 that it received a marketing authorization for its independently developed influenza vaccine “GC Flu” injection by the Korea Food and Drug Administration.

The company said the marketing authorization will contribute to stable supply of flu vaccine here and con...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK